Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models

Carine C Drewes,1,* Luana A Fiel,2,* Celina G Bexiga,1 Ana Carolina C Asbahr,3 Mayara K Uchiyama,4 Bruno Cogliati,5 Koiti Araki,4 Sílvia S Guterres,2,3 Adriana R Pohlmann,2,3,6 Sandra P Farsky1 1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, Universi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Drewes CC, Fiel LA, Bexiga CG, Asbahr ACC, Uchiyama MK, Cogliati B, Araki K, Guterres SS, Pohlmann AR, Farsky SP
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/c9f2962704f246238011510c3bcd7f56
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c9f2962704f246238011510c3bcd7f56
record_format dspace
spelling oai:doaj.org-article:c9f2962704f246238011510c3bcd7f562021-12-02T08:07:35ZNovel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models1178-2013https://doaj.org/article/c9f2962704f246238011510c3bcd7f562016-03-01T00:00:00Zhttps://www.dovepress.com/novel-therapeutic-mechanisms-determine-the-effectiveness-of-lipid-core-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Carine C Drewes,1,* Luana A Fiel,2,* Celina G Bexiga,1 Ana Carolina C Asbahr,3 Mayara K Uchiyama,4 Bruno Cogliati,5 Koiti Araki,4 Sílvia S Guterres,2,3 Adriana R Pohlmann,2,3,6 Sandra P Farsky1 1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, 2Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, 3Postgraduate Program in Pharmaceutical Nanotechnology, Federal University of Rio Grande do Sul, Porto Alegre, 4Department of Fundamental Chemistry, Institute of Chemistry, 5Department of Pathology, Faculty of Veterinary Medicine, University of São Paulo, São Paulo, 6Department of Organic Chemistry, Institute of Chemistry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil *These authors contributed equally to this work Abstract: Melanoma is a severe metastatic skin cancer with poor prognosis and no effective treatment. Therefore, novel therapeutic approaches using nanotechnology have been proposed to improve therapeutic effectiveness. Lipid-core nanocapsules (LNCs), prepared with poly(ε-caprolactone), capric/caprylic triglyceride, and sorbitan monostearate and stabilized by polysorbate 80, are efficient as drug delivery systems. Here, we investigated the effects of acetyleugenol-loaded LNC (AcE-LNC) on human SK-Mel-28 melanoma cells and its therapeutic efficacies on melanoma induced by B16F10 in C57B6 mice. LNC and AcE-LNC had z-average diameters and zeta potential close to 210 nm and -10.0 mV, respectively. CytoViva® microscopy images showed that LNC and AcE-LNC penetrated into SK-Mel-28 cells, and remained in the cytoplasm. AcE-LNC in vitro treatment (18–90×109 particles/mL; 1 hour) induced late apoptosis and necrosis; LNC and AcE-LNC (3–18×109 particles/mL; 48 hours) treatments reduced cell proliferation and delayed the cell cycle. Elevated levels of nitric oxide were found in supernatant of LNC and AcE-LNC, which were not dependent on nitric oxide synthase expressions. Daily intraperitoneal or oral treatment (days 3–10 after tumor injection) with LNC or AcE-LNC (1×1012 particles/day), but not with AcE (50 mg/kg/day, same dose as AcE-LNC), reduced the volume of the tumor; nevertheless, intraperitoneal treatment caused toxicity. Oral LNC treatment was more efficient than AcE-LNC treatment. Moreover, oral treatment with nonencapsulated capric/caprylic triglyceride did not inhibit tumor development, implying that nanocapsule supramolecular structure is important to the therapeutic effects. Together, data herein presented highlight the relevance of the supramolecular structure of LNCs to toxicity on SK-Mel-28 cells and to the therapeutic efficacy on melanoma development in mice, conferring novel therapeutic mechanisms to LNC further than a drug delivery system. Keywords: capric/caprylic triglycerides, mice, acetyleugenol, B16F10 cells, SK-Mel-28, nitric oxide, cell proliferation, nanotoxicologyDrewes CCFiel LABexiga CGAsbahr ACCUchiyama MKCogliati BAraki KGuterres SSPohlmann ARFarsky SPDove Medical PressarticleCapric/caprylic triglycerideslipid-core nanocapsulesacetyleugenolB16F10 cellsSK-Mel-28nitric oxidecell proliferationnanotoxicologyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2016, Iss default, Pp 1261-1279 (2016)
institution DOAJ
collection DOAJ
language EN
topic Capric/caprylic triglycerides
lipid-core nanocapsules
acetyleugenol
B16F10 cells
SK-Mel-28
nitric oxide
cell proliferation
nanotoxicology
Medicine (General)
R5-920
spellingShingle Capric/caprylic triglycerides
lipid-core nanocapsules
acetyleugenol
B16F10 cells
SK-Mel-28
nitric oxide
cell proliferation
nanotoxicology
Medicine (General)
R5-920
Drewes CC
Fiel LA
Bexiga CG
Asbahr ACC
Uchiyama MK
Cogliati B
Araki K
Guterres SS
Pohlmann AR
Farsky SP
Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
description Carine C Drewes,1,* Luana A Fiel,2,* Celina G Bexiga,1 Ana Carolina C Asbahr,3 Mayara K Uchiyama,4 Bruno Cogliati,5 Koiti Araki,4 Sílvia S Guterres,2,3 Adriana R Pohlmann,2,3,6 Sandra P Farsky1 1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, 2Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, 3Postgraduate Program in Pharmaceutical Nanotechnology, Federal University of Rio Grande do Sul, Porto Alegre, 4Department of Fundamental Chemistry, Institute of Chemistry, 5Department of Pathology, Faculty of Veterinary Medicine, University of São Paulo, São Paulo, 6Department of Organic Chemistry, Institute of Chemistry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil *These authors contributed equally to this work Abstract: Melanoma is a severe metastatic skin cancer with poor prognosis and no effective treatment. Therefore, novel therapeutic approaches using nanotechnology have been proposed to improve therapeutic effectiveness. Lipid-core nanocapsules (LNCs), prepared with poly(ε-caprolactone), capric/caprylic triglyceride, and sorbitan monostearate and stabilized by polysorbate 80, are efficient as drug delivery systems. Here, we investigated the effects of acetyleugenol-loaded LNC (AcE-LNC) on human SK-Mel-28 melanoma cells and its therapeutic efficacies on melanoma induced by B16F10 in C57B6 mice. LNC and AcE-LNC had z-average diameters and zeta potential close to 210 nm and -10.0 mV, respectively. CytoViva® microscopy images showed that LNC and AcE-LNC penetrated into SK-Mel-28 cells, and remained in the cytoplasm. AcE-LNC in vitro treatment (18–90×109 particles/mL; 1 hour) induced late apoptosis and necrosis; LNC and AcE-LNC (3–18×109 particles/mL; 48 hours) treatments reduced cell proliferation and delayed the cell cycle. Elevated levels of nitric oxide were found in supernatant of LNC and AcE-LNC, which were not dependent on nitric oxide synthase expressions. Daily intraperitoneal or oral treatment (days 3–10 after tumor injection) with LNC or AcE-LNC (1×1012 particles/day), but not with AcE (50 mg/kg/day, same dose as AcE-LNC), reduced the volume of the tumor; nevertheless, intraperitoneal treatment caused toxicity. Oral LNC treatment was more efficient than AcE-LNC treatment. Moreover, oral treatment with nonencapsulated capric/caprylic triglyceride did not inhibit tumor development, implying that nanocapsule supramolecular structure is important to the therapeutic effects. Together, data herein presented highlight the relevance of the supramolecular structure of LNCs to toxicity on SK-Mel-28 cells and to the therapeutic efficacy on melanoma development in mice, conferring novel therapeutic mechanisms to LNC further than a drug delivery system. Keywords: capric/caprylic triglycerides, mice, acetyleugenol, B16F10 cells, SK-Mel-28, nitric oxide, cell proliferation, nanotoxicology
format article
author Drewes CC
Fiel LA
Bexiga CG
Asbahr ACC
Uchiyama MK
Cogliati B
Araki K
Guterres SS
Pohlmann AR
Farsky SP
author_facet Drewes CC
Fiel LA
Bexiga CG
Asbahr ACC
Uchiyama MK
Cogliati B
Araki K
Guterres SS
Pohlmann AR
Farsky SP
author_sort Drewes CC
title Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
title_short Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
title_full Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
title_fullStr Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
title_full_unstemmed Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
title_sort novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/c9f2962704f246238011510c3bcd7f56
work_keys_str_mv AT drewescc noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT fiella noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT bexigacg noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT asbahracc noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT uchiyamamk noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT cogliatib noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT arakik noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT guterresss noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT pohlmannar noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
AT farskysp noveltherapeuticmechanismsdeterminetheeffectivenessoflipidcorenanocapsulesonmelanomamodels
_version_ 1718398689363361792